Single Center Experience In Transitioning Pulmonary Arterial Hypertension Patients From Intravenous Epoprostenol To Oral Selexipag

被引：0
|
作者：
Safdar, Z. [1 ]
机构：
[1] Weill Cornell Med, Houston Methodist Hosp, Houston, TX USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2288
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report
    Alexandre, Andre
    Furtado, Ines
    Carvalho, Luisa
    Goncalves, Fabienne
    Melo, Alzira
    Alves, Joana
    Santos, Mario
    Reis, Abilio
    [J]. ESC HEART FAILURE, 2023, 10 (04): : 2722 - 2727
  • [2] A Single Center Experience of Transitioning Stable Pulmonary Arterial Hypertension Patients from Parenteral Prostacyclin Therapy to Oral Selexipag
    Shah, T. G.
    Igenoza, O.
    Bartolome, S.
    Torres, F.
    Kingman, M.
    Harden, S.
    Chin, K. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] Transitioning Patients With Pulmonary Arterial Hypertension From Intravenous Prostacyclin to Oral Prostacyclin: Single-Center Experience
    Paulus, Sara
    Kallio, Adam
    Roberts, Eric
    Spexarth, Frank
    Zwicke, Dianne
    [J]. CHEST, 2015, 148 (04)
  • [4] Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution
    Yanaka, Kenichi
    Guillien, Alicia
    Soumagne, Thibaud
    Benet, Justin
    Piliero, Nicolas
    Picard, Francois
    Pison, Christophe
    Sitbon, Olivier
    Bouvaist, Helene
    Degano, Bruno
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (06)
  • [5] Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension
    Parikh, Kishan S.
    Doerfler, Sean
    Shelburne, Nicholas
    Kennedy, Karla
    Whitson, Jordan
    Dahhan, Talal
    Fortin, Terry
    Rajagopal, Sudarshan
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (04) : 299 - 304
  • [6] Transitioning Patients With Pulmonary Arterial Hypertension From Inhaled Prostacyclin to Oral Prostacyclin: Single-Center Experience
    Paulus, Sara
    Kallio, Adam
    Roberts, Eric
    Spexarth, Frank
    Zwicke, Dianne
    [J]. CHEST, 2015, 148 (04)
  • [7] Transitioning Stable Pulmonary Arterial Hypertension Patients from Parenteral Prostacyclin Therapy to Oral Selexipag
    Hinkamp, C. A.
    Bartolome, S.
    Torres, F.
    Igenoza, O.
    Kingman, M.
    Harden, S.
    Chin, K. M.
    Shah, T. G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] TRANSITIONING FROM PARENTERAL PROSTACYCLIN THERAPY TO ORAL SELEXIPAG IN PULMONARY ARTERIAL HYPERTENSION
    Budhram, Brandon
    Gardner, Andrea
    Hambly, Nathan
    [J]. CHEST, 2021, 160 (04) : 2219A - 2220A
  • [9] Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center
    Shirai, Yuichiro
    Yasuoka, Hidekata
    Takeuchi, Tsutomu
    Satoh, Toru
    Kuwana, Masataka
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (06) : 1211 - 1220
  • [10] Transitioning from intravenous epoprostenol to subcutaneous treprostinil in stable pulmonary arterial hypertension outpatients
    Lobacz, D
    Harris, K
    Roseigno, H
    Zwicke, DL
    Watson, J
    [J]. CHEST, 2004, 126 (04) : 760S - 760S
12345